CAITLIN AVERILL: Open Payments
NPI 1003200791 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 58 payments from 18 companies in 2025. Trend: 2023 $361 · 2024 $960 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $222 |
| PFIZER INC. | 8 | $170 |
| AstraZeneca Pharmaceuticals LP | 6 | $127 |
| ABBVIE INC. | 4 | $90 |
| Exact Sciences Corporation | 3 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Lilly USA, LLC | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Dexcom, Inc. | 3 | $51 |
| Astellas Pharma US Inc | 3 | $47 |
Products named: Ozempic, NURTEC ODT, JARDIANCE, Kerendia, AIRSUPRA, BREZTRI, The Cologuard Plus Collection Kit, Dexcom G6 Transmitter.
Industry payments across MD — which companies pay providers there.
